# Severe Aortic Stenosis and Regurgitation in a Young Athletic Doctor With Bicuspid Aortic Valve Managed With On-X® Mechanical Valve Replacement

**Authors:** Inderjeet Singh, Akash Xavier, Jayant Bajaj

PMC · DOI: 10.7759/cureus.95274 · Cureus · 2025-10-23

## TL;DR

A young, active doctor with a bicuspid aortic valve underwent mechanical valve replacement after developing severe heart valve issues.

## Contribution

This case highlights mechanical valve replacement as a viable option for young patients with anatomical constraints.

## Key findings

- Mechanical valve replacement was successful in a patient with a mismatched aortic annulus.
- Postoperative echocardiography showed improved valve function with a peak gradient of 11 mmHg.
- The patient was managed with a combination of medications including anticoagulants and beta-blockers.

## Abstract

We present the case of a 28-year-old athletic male physician with asymptomatic bicuspid aortic valve (BAV), diagnosed with severe aortic stenosis (AS) and moderate aortic regurgitation (AR) following self-auscultation prompted by nocturnal palpitations and chest vibrations. Echocardiography and computed tomography (CT) confirmed severe AS (peak gradient 79 mmHg, aortic valve area 0.6 cm²), moderate AR, and left ventricular hypertrophy. Due to an aortic annulus size mismatch, the Ross procedure was deemed unsuitable, and an On-X® (Artivion, Inc., Kennesaw, Georgia, United States) mechanical aortic valve was implanted. Postoperative echocardiography demonstrated a peak gradient of 11 mmHg and an ejection fraction of 55%. The patient was discharged on warfarin, aspirin, statins, beta-blockers, and calcium channel blockers with counseling on anticoagulation management. This case highlights the challenges of managing BAV in young, active patients and the role of mechanical valve replacement when anatomical constraints preclude other options.

## Linked entities

- **Chemicals:** warfarin (PubChem CID 54678486), aspirin (PubChem CID 2244)
- **Diseases:** aortic stenosis (MONDO:0042981)

## Full-text entities

- **Diseases:** AR (MESH:D001022), AS (MESH:D001024), BAV (MESH:D000082882), left ventricular hypertrophy (MESH:D017379), palpitations (MESH:D006331)
- **Chemicals:** warfarin (MESH:D014859), aspirin (MESH:D001241)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12640460/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12640460/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12640460/full.md

---
Source: https://tomesphere.com/paper/PMC12640460